logo

For the Inventor, By the Inventor

Omaha, NE, United States of America

Surinder K Batra

USPTO Granted Patents = 8

Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 14(Granted Patents)


Company Filing History:

goldMedal8 out of 937 
 
University of Nebraska
 patents

Years Active: 2003-2016

Loading Chart...
8 patents (USPTO):Explore Patents
1. 9403911 - Compositions and methods for detection and treatment of cancer (2016-08-02),
2. 9233121 - Compositions and methods for the treatment of cancer (2016-01-12),
3. 7166704 - Antibodies immunologically specific for PD2, a protein that is amplified and overexpressed in pancreatic cancer (2007-01-23),
4. 7105657 - Compositions and methods for inhibiting pancreatic cancer metastasis (2006-09-12),
5. 7078188 - MUC17 encoding nucleic acid sequences, polypeptides, antibodies and methods of use thereof (2006-07-18),
6. 7052859 - MUCIN 4 expression as a marker for pancreatic cancer (2006-05-30),
7. 6680196 - Gene that is amplified and overexpressed in cancer and methods of use thereof (2004-01-20),
8. 6576423 - Specific mucin expression as a marker for pancreatic cancer (2003-06-10),

Title: Surinder K Batra: Innovator in Cancer Detection and Treatment

Introduction

Surinder K Batra is a prominent inventor based in Omaha, NE (US), known for his significant contributions to the field of cancer research. With a total of 8 patents, he has developed innovative methods and compositions aimed at improving cancer detection and treatment.

Latest Patents

Batra's latest patents include groundbreaking work on compositions and methods for the detection and treatment of cancer. One notable patent focuses on novel antibodies designed for the detection and/or treatment of cancers such as pancreatic and ovarian cancer. These antibodies specifically bind to regions of the MUC4 protein that do not include the central tandem repeat (TR) domain. Additionally, certain antibodies target the MUC4 peptide fragments MUC4-α-N-Ter and MUC4-α-C-Ter. Another patent outlines compositions and methods for treating, detecting, and diagnosing cancer, showcasing Batra's commitment to advancing cancer therapies.

Career Highlights

Surinder K Batra is affiliated with the University of Nebraska, where he continues to push the boundaries of cancer research. His work has garnered attention for its potential to significantly impact cancer treatment protocols and improve patient outcomes.

Collaborations

Batra collaborates with esteemed colleagues, including Michael Anthony Hollingsworth and Nicolas Moniaux, to further enhance the scope and effectiveness of his research.

Conclusion

Surinder K Batra's innovative work in cancer detection and treatment exemplifies the vital role of inventors in advancing medical science. His contributions are paving the way for new therapeutic approaches that could transform cancer care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…